Study Suggests Ozempic and Wegovy May Help Reduce Heavy Drinking

A new clinical study suggests that the active ingredient used in Ozempic and Wegovy may help reduce heavy alcohol consumption among adults with alcohol use disorder, according toi, citing research from the University of Colorado Anschutz Medical Campus.

Researchers are studying whether GLP-1 medications such as Ozempic can help reduce heavy alcohol consumption.

Researchers described the findings as an important clinical step in addressing alcohol use disorder, a condition that remains significantly undertreated. The U.S. Food and Drug Administration (FDA) has approved only three medications for alcohol use disorder, with the most recent approval occurring in 2006.

An estimated 27.9 million Americans aged 12 and older experienced alcohol use disorder during the past year.

Separately, the report noted that more than 10,000 suspected cases of cyclossporiasis have been recorded in Michigan, where investigators continue working to identify the source of the outbreak.

Health officials said the incident has highlighted weaknesses in food safety testing and supply chain traceability.